ImmunityBio Financial Overview
ImmunityBio's market cap is currently $2.05B. The company's EPS TTM is $-0.07; its P/E ratio is -4.95; ImmunityBio is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.
